The Supreme Court will allow a challenge to Texas' controversial abortion law; the FDA broadens booster eligibility for teens; Kentucky declares an emergency over nurse shortages.
Although the law must remain in place throughout the duration, the Supreme Court announced it will permit a challenge against Texas' controversial abortion law, known as S.B.8., The New York Times reports. The law, which bans most abortions after 6 weeks of pregnancy and has no exceptions for rape or incest, has stoked controversy since it was put into effect in September. Specifically, the Supreme Court will allow abortion providers in the state to sue some state officials in federal court. S.B.8. permits private individuals to sue anyone in the state who performs an abortion or aids or abets the procedure.
The FDA has endorsed providing Pfizer/BioNTech booster shots to those aged 16 and 17, USAToday reports. Hours after the FDA authorized the move, the CDC recommended these teens receive the boosters as soon as 6 months have passed following their initial shots. The third dose of the Pfizer/BioNTech vaccine is identical to the previous 2 in the regimen. Booster doses are already encouraged for those aged 18 and older who received any of the 3 approved vaccines. All booster doses will be free of charge to those who qualify.
Kentucky has declared an emergency due to a chronic lack of nurses, according to The Associated Press. As a result, Governor Andrew Beshear took executive actions to boost enrollment in nurse training programs throughout the state. By 2024, the state is projected to need over 16,000 additional nurses to help fill gaps resulting from retirement or individuals leaving the profession. The COVID-19 pandemic also has exacerbated nursing shortages across the country, as many leave because of exhaustion or the demoralizing nature of the job, or take more lucrative positions with travelling nurse agencies.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
2 Commerce Drive
Cranbury, NJ 08512